Men’s Health M&A Market
The global men’s health market is valued at $2.8 trillion and has a forecasted 12.5% CAGR increase between 2024 and 2030 for the men’s health and wellness sector [1].
In the UK, rapid digital health innovation and the government’s first-ever strategic response has meant that the men’s health sector is currently undergoing a shift that is breaking long-standing stigma and moving the market from low engagement to systemic change.
Our latest insights paper explores the forces driving this growth and outlines the broader M&A outlook for the men’s health sector.
Key Influences:
- Government Strategy: The UK’s first 10-year Men’s Health Strategy, mandates systemic reforms, including trials of at-home PSA kits and targeted suicide prevention funding.
- Digital Health Adoption: Platforms enable wider access to men’s health through various models such as telehealth, subscription, and prescription delivery.
- NHS Capacity Gaps: Market consolidation, for example that integrates home diagnostics with specialist TRT pathways, addresses capacity gaps.
- Fertility Innovation: At-home sperm analysis kits decentralise testing, empowering men in family planning.
- Holistic Sexual Health: Platforms expand beyond medication to psychosexual therapy and coaching, reflecting demand for integrated mental and physical care.
- International Expansion: Global operators are targeting the UK & European markets, backed by significant fundraising to scale digital-first models internationally.
To learn more about the trends shaping the Men’s Health space, read our latest paper.
If you would like to know more about the Men’s Health M&A landscape after reading this paper, or have any other questions on the wider healthcare space, please do get in touch with Al-Munther Sultan.
Sources:
[1] Research & Markets (2024-2030 data)
